PUBLISHED: Centricity Research Physicians publish paper on the burden of NAFLD in Canada
Research physicians at Centricity Research have joined forces with noted…
A Simple Guide to Understanding Vaccines – How exactly do they work?
The stigma surrounding what vaccines do and how they really work can be…
Check out the most recent publication about The Canadian Diabetes Prevention Program (CDPP) on The Globe and Mail!
The Canadian Diabetes Prevention Program (CDPP) is a collaboration of Diabetes…
First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes
This month, our newest publication is the full report of the Eversense study…
RESEARCH SPOTLIGHT: Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemia
Centricity Research’s Chief Medical officer Dr. Ronnie Aronson shares…
RESEARCH SPOTLIGHT: Reproducibility in the cardiometabolic responses to high-intensity interval exercise in adults with type 1 diabetes
With one month of 2019 already completed, we are excited to share a 2nd FIT…
RESEARCH SPOTLIGHT: Optimal Insulin Correction Factor in Post–High-Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes: The FIT Study
On Monday November 19th, Centricity Research’s own Type 1 Diabetes &…
Manuscript Accepted: SGLT2 inhibitors and incretin agents: associations with alanine aminotransferase activity in type 2 diabetes
LMC Healthcare & Centricity Researches own Drs. Ronnie Aronson, Harpreet…
Randomized Trial of Long-Acting Insulin Glargine Titration Web Tool (LTHome) Versus Enhanced Usual Therapy of Glargine Titration (INNOVATE Trial)
LMC Diabetes & Endocrinology’s Innovate Trial has was posted in…
Dr Aronson's Paper Published in TouchEndocrinology.com's 2015 Summer Issue
Dr. Ronnie Aronson’s paper “The Functionally Refractory Patient in…